Volume 16, Number 9—September 2010
Research
Trends in Hospitalizations for Peptic Ulcer Disease, United States, 1998–20051
Table 1
Number of hospitalizations and age-adjusted and age-specific rates of hospitalization for first-listed discharge diagnoses of peptic ulcer disease, overall and by sex, United States, 1998–2005*
| Characteristic |
Male patients | Female patients | Overall | |||||
|---|---|---|---|---|---|---|---|---|
| No. (SE) |
Rate† (95% CI) |
No. (SE) |
Rate† (95% CI) |
No. (SE) |
Rate† (95% CI) |
|||
| Age, y | ||||||||
| <20 | 7,851 (320) | 2.4 (2.2–2.6) | 4,926 (349) | 1.6 (1.4–1.8) | 12,803 (602) | 2.0 (1.8–2.2) | ||
| 20–44 | 113,742 (1,344) | 27.0 (26.4–27.6) | 72,638 (945) | 17.5 (17.1–18.0) | 186,557 (1,979) | 22.3 (21.8–22.8) | ||
| 45–64 | 236,381 (2,206) | 92.6 (90.9–94.3) | 165,013 (1,628) | 61.3 (60.2–62.5) | 401,581 (3,480) | 76.6 (75.3–77.9) | ||
| >65 |
380,016 (3,555) |
322.5 (316.6–328.4) |
472,590 (4,224) |
283.6 (278.6–288.6) |
852,720 (7,409) |
299.8 (294.7–304.9) |
||
| Race/ethnicity‡ | ||||||||
| White | 392,199 (5,508) | 48.7 (47.7–49.6) | 408,120 (5,712) | 40.4 (39.5–41.2) | 800,358 (10,974) | 44.2 (43.3–45.0) | ||
| Black | 70,453 (1,968) | 69.7 (67.1–72.3) | 59,045 (1,733) | 46.4 (44.5–48.2) | 129,499 (3,577) | 56.8 (54.7–58.8) | ||
| Hispanic | 48,076 (1,661) | 58.4 (55.1–61.7) | 33,179 (1,324) | 38.7 (36.1–41.2) | 81,270 (2,887) | 48.0 (45.3–50.8) | ||
| Asian/Pacific Islander |
23,268 (1,158) |
68.2 (63.0–73.5) |
14,789 (767) |
38.1 (34.7–41.6) |
38,056 (1,846) |
51.8 (47.8–55.8) |
||
| Ulcer type | ||||||||
| Gastric | 343,079 (3,011) | 33.5 (33.1–34.0) | 427,469 (3,750) | 33.6 (33.1–34.0) | 770,785 (6,347) | 33.7 (33.3–34.2) | ||
| Peptic | 40,009 (678) | 3.8 (3.7–3.9) | 51,452 (818) | 4.1 (4.0–4.2) | 91,524 (1,313) | 4.0 (3.9–4.1) | ||
| Duodenal | 340,161 2,973 | 33.1 (32.9–33.5) | 217,946 (2,055) | 17.1 (16.8–17.4) | 558,443 (4,676) | 24.4 (24.1–24.7) | ||
| Gastrojejunal |
14,772 (335) |
1.4 (1.4–1.5) |
18,336 (504) |
1.5 (1.4–1.6) |
33,142 (699) |
1.4 (1.4–1.5) |
||
| Total | 738,020 (5,897) | 71.9 (71.0–72.7) | 715,203 (5,824) | 56.3 (55.6–57.0) | 1,453,892 (11,201) | 63.6 (62.9–64.3) | ||
*Diagnosis codes 531–534 from the International Classification of Diseases, 9th Revision, Clinical Modification. National estimates determined by using the Nationwide Inpatient Sample (21).
†Per 100,000 population.
‡Race/ethnicity was missing for 26.0% of hospitalized patients. Data were insufficient for the race/ethnicity category of American Indian/Alaska Native.
1Presented in part at the Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and Infectious Diseases Society of America; 2008 Oct 28; Washington, DC (abstract number L-4129).
2Current affiliation: University of North Carolina, Chapel Hill, North Carolina, USA.
